Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00446225
Status:
COMPLETED
Last Update Posted:
2022-06-13
First Post:
2007-03-08
Brief Title:
Phase III Study Tarceva vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR
Sponsor:
Spanish Lung Cancer Group
Organization:
Spanish Lung Cancer Group
Organization Data
Organization:
Spanish Lung Cancer Group
Class:
OTHER
Study ID:
EURTAC-SLCG GECP0601
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Spanish Lung Cancer Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None